Get started
Author

Joseph Dresser

Observed names: Dresser, Joseph, J. Dresser, Joseph J. Dresser
OpenAlex ID: A5085670165
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
2020 · Weihua Zhou, Yangyang Yao, et al. · Nature Communications · 242
PDF
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
2016 · Daniel R. Wahl, Joseph Dresser, et al. · Cancer Research · 95
Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
2020 · Barbara S. Nelson, Lin Lin, et al. · Cancer & Metabolism · 50
PDF
Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
2020 · Christian K. Werner, Uchechi J. Nna, et al. · Molecular Cancer Therapeutics · 35
Exth-15. Targeting Androgen Signaling in Glioblastoma (gbm) Using Seviteronel (sevi), a Cyp17 Lyase and Androgen Receptor (ar) Inhibitor, Alone and in Combination With Radiation (rt)
2018 · Hanshi Sun, Christian Werner, et al. · Neuro-Oncology · 4
Ddre-24. Targeting Purine Metabolism to Overcome Glioblastoma Therapy Resistance
2021 · Weihua Zhou, Yangyang Yao, et al. · Neuro-Oncology Advances · 1
PDF
Supplementary Data and Methods from Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
2023 · Christian K. Werner, Uchechi J. Nna, et al.
Supplementary Data and Methods from Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
2023 · Christian K. Werner, Uchechi J. Nna, et al.
PDF
Data from Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
2023 · Christian K. Werner, Uchechi J. Nna, et al.
Data from Expression of the Androgen Receptor Governs Radiation Resistance in a Subset of Glioblastomas Vulnerable to Antiandrogen Therapy
2023 · Christian K. Werner, Uchechi J. Nna, et al.
Data from Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
2023 · Daniel R. Wahl, Joseph Dresser, et al.
Supplementary Data from Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
2023 · Daniel R. Wahl, Joseph Dresser, et al.
Data from Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
2023 · Daniel R. Wahl, Joseph Dresser, et al.
Supplementary Data from Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
2023 · Daniel R. Wahl, Joseph Dresser, et al.
PDF
Abstract 6267: Repurposing antiandrogens to overcome therapy resistance in androgen receptor-positive glioblastoma
2020 · Christian K. Werner, Uchechi Nna, et al. · Cancer Research
MOESM3 of Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
2020 · Nelson, Barbara, Lin, Lin, et al. · Figshare
MOESM2 of Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy
2020 · Nelson, Barbara, Lin, Lin, et al. · Figshare
De Novo Purine Synthesis Is a Targetable Vulnerability That Confers Radiation Resistance and Inferior Patient Survival in IDH-Wild Type Diffuse Glioma
2019 · W. Zhou, Y. Yao, et al. · International Journal of Radiation Oncology*Biology*Physics
Inhibiting Isocitrate Dehydrogenase 1-Mediated Reductive Biosynthesis to Augment Glioblastoma Therapy
2016 · D.R. Wahl, J. Dresser, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Works count: 22
Citation count: 427
H-index: 4
I10-index: 4
Year
Topic
Type